China Pharmaceutical (600056.SH) subsidiary obtains drug registration certificate for nimergoline tablets

Zhitongcaijing · 3d ago

Zhitong Finance App News, China Pharmaceutical (600056.SH) issued an announcement. Recently, Hainan GM Sanyo Pharmaceutical Co., Ltd. (“Sanyang Pharmaceutical”), a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for nimegoline tablets approved and issued by the State Drug Administration. Nimergoline tablets are mainly used to improve low motivation due to the sequelae of a stroke; they are also suitable for vascular dementia. In particular, during early treatment, they improve cognition, memory, etc., and can reduce the severity of the disease.